Abbott: Hyperparathyroidism, Secondary trials

The registry lists 11 Hyperparathyroidism, Secondary studies with Abbott as lead sponsor. 0 are open to participants now and 9 have results posted.

Phase 2 3Phase 4 7No phase 1(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Follow-up Patients With End Stage Renal Disease Receiving Zemplar to Prevent and Treat Secondary HyperparathyroidismCompletedNCT01081665Results posted
• Paricalcitol Compared to Maxacalcitol in Chronic Kidney Disease Patients With Secondary HyperparathyroidismCompletedNCT00990704Phase 2Results posted
• Evaluation of the Effectiveness of Paricalcitol Versus Cinacalcet With Low-Dose Vitamin DCompletedNCT00977080Phase 4Results posted
• Effectiveness and Safety of IV Zemplar in Patients on Hemodialysis and With Secondary Hyperparathyroidism Using iPTH/100 as Initial DoseCompletedNCT00891813Phase 4Results posted
• Long-term Safety Study of Paricalcitol Injection in Chronic Kidney Disease Patients With Hemodialysis (HD)CompletedNCT00701805Phase 2Results posted
• Dose-response Study of Paricalcitol Injection in Chronic Kidney Disease Patients Receiving HemodialysisCompletedNCT00667576Phase 2Results posted
• Efficacy and Safety of Paricalcitol on the Treatment of Secondary Hyperparathyroidism in Calcitriol Resistant Dialysis SubjectsTerminatedNCT00664430Phase 4Results posted
• Efficacy and Safety of 6 Months Treatment With Paricalcitol Injection or Oral in Patients With Secondary Hyperparathyroidism on DialysisCompletedNCT00537979Phase 4Results posted
• A Study of Zemplar® Injection and Hectorol® Injection on Intestinal Absorption of Calcium in Chronic Kidney DiseaseCompletedNCT00257920Phase 4Results posted
• Study to Evaluate the Effects of Zemplar Injection and Calcijex on Intestinal Absorption of CalciumCompletedNCT00073710Phase 4
• Safety and Effectiveness of Zemplar Injection in Decreasing iPTH Levels in Pediatric ESRD Subjects on HemodialysisCompletedNCT00053547Phase 4